{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:26:24Z","timestamp":1767968784217,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11606-021-06739-z","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T19:02:40Z","timestamp":1617044560000},"page":"2448-2451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advanced Inpatient Management of Opioid Use Disorder in a Patient Requiring Serial Surgeries"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-1053","authenticated-orcid":false,"given":"Parisa","family":"Mortaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Moo-Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"6739_CR1","unstructured":"US Dept of HHS O of the SG. Facing Addiction in America: the Surgeon General\u2019s Spotlight on Opioids. 2018:35. https:\/\/addiction.surgeongeneral.gov\/sites\/default\/files\/Spotlight-on-Opioids_09192018.pdf."},{"key":"6739_CR2","unstructured":"Center for Behavioral Health Statistics and Quality. 2017 National Survey on Drug Use and Health: Detailed Tables. SAMHSA; 2018:2871. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHDetailedTabs2017\/NSDUHDetailedTabs2017.pdf."},{"issue":"5","key":"6739_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jpainsymman.2013.03.001","volume":"45","author":"B Foster","year":"2013","unstructured":"Foster B, Twycross R, Mihalyo M, Wilcock A. Buprenorphine. J Pain Symptom Manag. 2013;45(5):939-949. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.03.001.","journal-title":"J Pain Symptom Manag."},{"issue":"3","key":"6739_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","volume":"103","author":"A Gibson","year":"2008","unstructured":"Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O\u2019Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction. 2008;103(3):462-468. https:\/\/doi.org\/10.1111\/j.1360-0443.2007.02090.x.","journal-title":"Addiction."},{"issue":"3","key":"6739_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137-145. https:\/\/doi.org\/10.7326\/M17-3107.","journal-title":"Ann Intern Med."},{"key":"6739_CR6","unstructured":"SAMHSA. Buprenorphine. Published May 31, 2016. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/treatment\/buprenorphine."},{"issue":"3","key":"6739_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/pm\/pny019","volume":"20","author":"A Lembke","year":"2019","unstructured":"Lembke A, Ottestad E, Schmiesing C. Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through the perioperative period. Pain Med. 2019;20(3):425-428. https:\/\/doi.org\/10.1093\/pm\/pny019.","journal-title":"Pain Med."},{"issue":"1","key":"6739_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pmn.2019.08.003","volume":"21","author":"BS Marie","year":"2020","unstructured":"Marie BS, Broglio K. Managing pain in the setting of opioid use disorder. Pain Manag Nurs. 2020;21(1):26-34. https:\/\/doi.org\/10.1016\/j.pmn.2019.08.003.","journal-title":"Pain Manag Nurs."},{"key":"6739_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/SAR.S109919","volume":"7","author":"R H\u00e4mmig","year":"2016","unstructured":"H\u00e4mmig R, Kemter A, Strasser J, et al. Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method. Subst Abuse Rehabil. 2016;7:99-105. https:\/\/doi.org\/10.2147\/SAR.S109919.","journal-title":"Subst Abuse Rehabil."},{"issue":"10","key":"6739_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/phar.2313","volume":"39","author":"D Terasaki","year":"2019","unstructured":"Terasaki D, Smith C, Calcaterra SL. Transitioning hospitalized patients with opioid use disorder from methadone to buprenorphine without a period of opioid abstinence using a microdosing protocol. Pharmacotherapy. 2019;39(10):1023-1029. https:\/\/doi.org\/10.1002\/phar.2313.","journal-title":"Pharmacotherapy."},{"key":"6739_CR11","doi-asserted-by":"publisher","unstructured":"Thakrar S, Lee J, Martin CE, Iv JB. Buprenorphine management: a conundrum for the anesthesiologist and beyond - a one-act play. Reg Anesth Pain Med. 2020. https:\/\/doi.org\/10.1136\/rapm-2020-101294.","DOI":"10.1136\/rapm-2020-101294"},{"issue":"2","key":"6739_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1213\/ANE.0000000000004018","volume":"129","author":"DA Edwards","year":"2019","unstructured":"Edwards DA, Hedrick TL, Jayaram J, et al. American society for enhanced recovery and perioperative quality initiative joint consensus statement on perioperative management of patients on preoperative opioid therapy. Anesth Analg. 2019;129(2):553\u2013566. https:\/\/doi.org\/10.1213\/ANE.0000000000004018.","journal-title":"Anesth Analg."},{"issue":"2","key":"6739_CR13","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/j.bja.2019.03.044","volume":"123","author":"A Goel","year":"2019","unstructured":"Goel A, Azargive S, Weissman JS, et al. Perioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process. Br J Anaesth. 2019;123(2):e333-e342. https:\/\/doi.org\/10.1016\/j.bja.2019.03.044.","journal-title":"Br J Anaesth."},{"key":"6739_CR14","doi-asserted-by":"publisher","unstructured":"Buresh M, Ratner J, Zgierska A, Gordin V, Alvanzo A. Treating perioperative and acute pain in patients on buprenorphine: narrative literature review and practice recommendations. J Gen Intern Med. 2020. https:\/\/doi.org\/10.1007\/s11606-020-06115-3.","DOI":"10.1007\/s11606-020-06115-3"},{"key":"6739_CR15","doi-asserted-by":"publisher","unstructured":"White LD, Hodge A, Vlok R, Hurtado G, Eastern K, Melhuish TM. The efficacy and adverse effects of buprenorphine in acute pain management: a systematic review and meta-analysis of randomised controlled trials. Br J Anaesth. https:\/\/doi.org\/10.1016\/j.bja.2017.11.086.","DOI":"10.1016\/j.bja.2017.11.086"},{"key":"6739_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2147\/JPR.S85951","volume":"8","author":"IK Khanna","year":"2015","unstructured":"Khanna IK, Pillarisetti S. Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res. 2015;8:859-870. https:\/\/doi.org\/10.2147\/JPR.S85951.","journal-title":"J Pain Res."},{"issue":"2","key":"6739_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1213\/ANE.0000000000003477","volume":"127","author":"EN Ward","year":"2018","unstructured":"Ward EN, Quaye AN-A, Wilens TE. Opioid use disorders: perioperative management of a special population. Anesth Analg. 2018;127(2):539-547. https:\/\/doi.org\/10.1213\/ANE.0000000000003477.","journal-title":"Anesth Analg."},{"issue":"10","key":"6739_CR18","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/pm\/pnx277","volume":"19","author":"J Myers","year":"2018","unstructured":"Myers J, Compton P. Addressing the potential for perioperative relapse in those recovering from opioid use disorder. Pain Med. 2018;19(10):1908-1915. https:\/\/doi.org\/10.1093\/pm\/pnx277.","journal-title":"Pain Med."},{"issue":"2","key":"6739_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/0310057X1304100212","volume":"41","author":"PE Macintyre","year":"2013","unstructured":"Macintyre PE, Russell RA, Usher KAN, Gaughwin M, Huxtable CA. Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy. Anaesth Intensive Care. 2013;41(2):222-230. https:\/\/doi.org\/10.1177\/0310057X1304100212.","journal-title":"Anaesth Intensive Care."},{"issue":"3","key":"6739_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","volume":"59","author":"DA Volpe","year":"2011","unstructured":"Volpe DA, McMahon Tobin GA, Mellon RD, et al. Uniform assessment and ranking of opioid \u03bc receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol. 2011;59(3):385-390. https:\/\/doi.org\/10.1016\/j.yrtph.2010.12.007.","journal-title":"Regul Toxicol Pharmacol."},{"issue":"2","key":"6739_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1124\/jpet.106.118810","volume":"321","author":"D Wang","year":"2007","unstructured":"Wang D, Sun X, Sadee W. Different effects of opioid antagonists on Mu-, Delta-, and Kappa-opioid receptors with and without agonist pretreatment. J Pharmacol Exp Ther. 2007;321(2):544-552. https:\/\/doi.org\/10.1124\/jpet.106.118810.","journal-title":"J Pharmacol Exp Ther."},{"issue":"4 Suppl","key":"6739_CR22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","volume":"18","author":"CE Inturrisi","year":"2002","unstructured":"Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain. 2002;18(4 Suppl):S3-13. https:\/\/doi.org\/10.1097\/00002508-200207001-00002.","journal-title":"Clin J Pain."},{"key":"6739_CR23","unstructured":"Roxane Laboratories, Inc. Dolophine [package insert]. Published online April 2015. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/006134s038lbl.pdf."},{"key":"6739_CR24","unstructured":"Indivior, Inc. Suboxone [package insert]. Published online October 2019. https:\/\/www.suboxone.com\/pdfs\/prescribing-information.pdf."},{"issue":"4","key":"6739_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/CXA.0000000000000072","volume":"10","author":"SM Ghosh","year":"2019","unstructured":"Ghosh SM, Klaire S, Tanguay R, Manek M, Azar P. A review of novel methods to support the transition from methadone and other full agonist opioids to buprenorphine\/naloxone sublingual in both community and acute care settings. Can J Addict. 2019;10(4):41\u201350. https:\/\/doi.org\/10.1097\/CXA.0000000000000072.","journal-title":"Can J Addict."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-021-06739-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-06739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:54:04Z","timestamp":1648515244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-021-06739-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6739"],"URL":"https:\/\/doi.org\/10.1007\/s11606-021-06739-z","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"14 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}